城地香江(603887.SH):首發部分募投項目結項並將節餘募集資金永久補充流動資金
格隆匯11月7日丨城地香江(603887.SH)公佈,公司於2021年11月5日召開第四屆董事會第四次會議和第四屆監事會第四次會議,會議審議通過了《關於公司首次公開發行部分募投項目結項並將節餘募集資金永久補充流動資金的議案》。考慮到公司已戰略轉型及首次公開發行股票並募集資金投資項目的實際情況和對建築施工業行業整體的判斷,為進一步提高公司資金使用效率,公司同意對前述部分募投項目進行結項並將節餘募集資金永久補充流動資金,同時對相應募集資金賬户作銷户處理。此次結項的募投項目為地基專用裝備升級改造及補充配套營運資金項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.